GL1X · GenesisL1 explorer

MolNFT v1 · #122098 · protein

Discovery of potent myeloid cell leukemia-1 (mcl-1) inhibitors using structure-based design

5IF4 · Induced myeloid leukemia cell differentiation protein mcl- 1: “Discovery of potent myeloid cell leukemia-1 (mcl-1) inhibitors using structure-based design”. X-ray diffraction, 1 ligand (6AK), 2 pockets (best druggability 0.67).…

PDB
5IF4
Type
protein
Length
305 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Induced myeloid leukemia cell differentiation protein mcl- 1
UniProt
Q07820
Ligands
6AK
Pockets
2 · best druggability 0.67

Structure

x-ray diffraction · 2 distinct chains · 78% helix, 0% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AInduced myeloid leukemia cell differentiation protein mcl- 1protein15179% helix, 0% strandQ07820
BInduced myeloid leukemia cell differentiation protein mcl- 1protein15477% helix, 0% strandQ07820

Ligands and binding sites

  • 6AK · 4-{8-chloro-11-[3-(4-chloro-3,5-dimethylphenoxy)propyl]-1-oxo-7-(1,3,5-trimethyl-1H-pyrazol-4-yl)-4,5-dihydro-1H-[1,4]diazepino[1,2-a]indol-2(3H)-yl}-1-methyl-1H-indole-6-carboxylic acid · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11720.670.86206AK
21770.660.85226AK

Interfaces

1 interface between chains.

  • A–B · 647 Ų buried · 10 hydrogen bonds · protein-protein

Compared structures

  • 5IF4 · Discovery of Potent Myeloid Cell Leukemia-1 (Mcl-1) inhibitors using Structure-Based… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.